Silvia C. Formenti

Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.

Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesions.

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

Breast, chest wall, and nodal irradiation with prone set-up: Results of a hypofractionated trial with a median follow-up of 35 months.

Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes.

Subverting misconceptions about radiation therapy.

Quality of Life in Women Undergoing Breast Irradiation in a Randomized, Controlled Clinical Trial Evaluating Different Tumor Bed Boost Fractionations.

Prospective Randomized Trial of Prone Accelerated Intensity Modulated Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed.

The Pace of Progress in Radiation and Immunotherapy.

Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure.

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.

Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.

Does Heavy Ion Therapy Work Through the Immune System?

Preplanning prediction of the left anterior descending artery maximum dose based on patient, dosimetric, and treatment planning parameters.

Emotional Intelligence and Burnout in Academic Radiation Oncology Chairs.

Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.

Trial watch: Immune checkpoint blockers for cancer therapy.

Integration of radiation and immunotherapy in breast cancer - Treatment implications.

Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers.

Optimizing Dose Per Fraction: A New Chapter in the Story of the Abscopal Effect?

Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer.

Dual Transforming Growth Factor-β and Programmed Death-1 Blockade: A Strategy for Immune-Excluded Tumors?

Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway.

The Integration of Radiotherapy with Immunotherapy for the Treatment of Non-Small Cell Lung Cancer.

Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect.

Cytosolic DNA Sensing in Organismal Tumor Control.

Introduction to the special edition on immunotherapy and radiation oncology.

Estimating child mortality associated with maternal mortality from breast and cervical cancer.

Radiotherapy induces responses of lung cancer to CTLA-4 blockade.

Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system.

Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients.

The abscopal effect 67 years later: from a side story to center stage.

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.

Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy.

Immunomodulation by anticancer cell cycle inhibitors.

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.

Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.

Radiation Therapy and the In Situ Vaccination Approach.

Future of Radiation and Immunotherapy.

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.

Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade.

Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.

Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER Breast Cancer.

Development of a Model to Estimate the Association Between Delay in Cancer Treatment and Local Tumor Control and Risk of Metastases.

Liver Metastasis Irradiation Can Restore Immunotherapeutic Responsiveness.

Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?

Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy).

Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer.

Author Correction: Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer.

Cellular senescence in the response of HR breast cancer to radiotherapy and CDK4/6 inhibitors.

Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.

Immunologically relevant effects of radiation therapy on the tumor microenvironment.

Emerging evidence for adapting radiotherapy to immunotherapy.